Table 2.
Patient and tumor characteristics.
| FEV1, L | |
| Mean | 1.22 |
| Range | 0.53–3.06 |
| PREDICTED FEV1 (%) | |
| Mean | 57 |
| Range | 21–111 |
| DLCO (mL/min/mmHg) | |
| Mean | 9.99 |
| Range | 3.49–23.30 |
| MEAN % PREDICTED DLCO | |
| Mean | 55 |
| Range | 14–128 |
| ECOG | |
| Median | 1 |
| Range | 0–2 |
| AGE (YEARS) | |
| Median | 76 |
| Range | 63–87 |
| SEX (%) | |
| Male | 40 |
| Female | 60 |
| RACE (%) | |
| Caucasian | 82.5 |
| African | 17.5 |
| SMOKER (%) | |
| Yes | 95 |
| No | 5 |
| HISTOLOGY (%) | |
| Adenocarcinoma | 48 |
| Squamous cell carcinoma | 30 |
| NSCLC NOS | 22 |
| CLINICAL STAGE (%) | |
| T1N0 | 60 |
| T2N0 | 40 |
| MAXIMUM DIAMETER (cm) | |
| Mean | 2.87 |
| Median | 2.60 |
| Range | 1.40–5.00 |